Alphatec Holdings (ATEC) Cash from Investing Activities Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Alphatec Holdings | 1.15 Bn | 1.01 Bn | 136.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.21% |
| Dec 31, 2025 | -7.39% |
| Sep 30, 2025 | -18.83% |
| Jun 30, 2025 | -22.86% |
| Mar 31, 2025 | -34.59% |
| Dec 31, 2024 | -7.62% |
| Sep 30, 2024 | -24.22% |
| Jun 30, 2024 | -68.42% |
| Mar 31, 2024 | -99.34% |
| Dec 31, 2023 | -52.09% |
| Sep 30, 2023 | -63.70% |
| Jun 30, 2023 | -101.04% |
| Mar 31, 2023 | -3.61% |
| Dec 31, 2022 | -141.93% |
| Sep 30, 2022 | -74.42% |
| Jun 30, 2022 | -33.72% |
| Mar 31, 2022 | -46.64% |
| Dec 31, 2021 | -59.13% |
| Sep 30, 2021 | -16.96% |
| Jun 30, 2021 | -98.53% |
| Mar 31, 2021 | -85.92% |
| Dec 31, 2020 | -25.71% |
| Sep 30, 2020 | -31.66% |
| Jun 30, 2020 | -2.77% |
| Mar 31, 2020 | 5.36% |
| Dec 31, 2019 | 6.07% |
| Sep 30, 2019 | -18.50% |
| Jun 30, 2019 | 2.98% |
| Mar 31, 2019 | 6.49% |
| Dec 31, 2018 | -0.53% |
| Sep 30, 2018 | 12.49% |
| Jun 30, 2018 | 24.55% |
| Mar 31, 2018 | -38.44% |
| Dec 31, 2017 | 51.34% |
| Sep 30, 2017 | 25.39% |
| Jun 30, 2017 | 8.05% |
| Mar 31, 2017 | 10.89% |
| Dec 31, 2016 | -36.21% |
| Sep 30, 2016 | 78.17% |
| Jun 30, 2016 | -6.46% |
| Mar 31, 2016 | 13.90% |
| Dec 31, 2015 | 3.40% |
| Sep 30, 2015 | 23.30% |